November 8, 2017 Toulouse, FRANCE, Lakeland, UNITED STATES, CERENIS Therapeutics (FR0012616852 â CEREN â PEA PME eligible) an international biopharmaceutical company dedicated to the discovery and development of HDL-based innovative therapies for treating cardiovascular and metabolic diseases, today announces the acquisition of LYPRO Biosciences assets, a portfolio of proprietary drug delivery nanotechnology. The operation positions CERENIS at the forefront of the chemotherapy drug delivery and immuno-oncology space. This represents a significant step towards the Companyâsstrategic objective of developing the next generation of multiple targeted drug delivery nanotechnologies associated with HDL therapy.
Location: United States, California, Berkeley
Member count: 11-50
Total raised: $65.870402M
Founded date: 2005
Investors 1
Date | Name | Website |
- | Xandex Ven... | xandexvent... |
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
21.10.2010 | Series C | $13.955253... | - | finsmes.co... |
26.07.2010 | Series C | $51.915149... | - | finsmes.co... |
Mentions in press and media 41
Date | Title | Description | Category | Author | Source |
23.08.2011 | Venture Fi... | Share Share on Facebook Share ... | - | Sarah Schm... | xconomy.co... |
22.10.2010 | Cerenis Th... | The company has several choles... | - | - | medcitynew... |
21.10.2010 | Cerenis Th... | Cerenis Therapeutics, a biopha... | France fu... | - | finsmes.co... |
26.07.2010 | Cerenis Th... | Promoted This Patient Experie... | - | - | medcitynew... |
26.07.2010 | Cerenis Th... | Cerenis Therapeutics SA, a Tou... | France fu... | - | finsmes.co... |
- | CERENIS Th... | • Combining LYPRO Biosciences’... | - | - | healthcap.... |
- | CER-001: A... | Toulouse, FRANCE, Ann Arbor, U... | - | - | healthcap.... |
- | Positive s... | Professor Alberto Corsini, Dep... | - | - | healthcap.... |
- | New Data f... | Data show that CER-001 at 3 mg... | - | - | healthcap.... |
- | Cerenis Re... | TOULOUSE, France and ANN ARBOR... | - | - | healthcap.... |
Show more